515 reports of this reaction
1.9% of all KETOCONAZOLE CREAM, 2% reports
#11 most reported adverse reaction
DYSPNOEA is the #11 most commonly reported adverse reaction for KETOCONAZOLE CREAM, 2%, manufactured by Encube Ethicals, Inc.. There are 515 FDA adverse event reports linking KETOCONAZOLE CREAM, 2% to DYSPNOEA. This represents approximately 1.9% of all 27,109 adverse event reports for this drug.
Patients taking KETOCONAZOLE CREAM, 2% who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DYSPNOEA is a less commonly reported adverse event for KETOCONAZOLE CREAM, 2%, but still significant enough to appear in the safety profile.
In addition to dyspnoea, the following adverse reactions have been reported for KETOCONAZOLE CREAM, 2%:
The following drugs have also been linked to dyspnoea in FDA adverse event reports:
DYSPNOEA has been reported as an adverse event in 515 FDA reports for KETOCONAZOLE CREAM, 2%. This does not prove causation, but indicates an association observed in post-market surveillance data.
DYSPNOEA accounts for approximately 1.9% of all adverse event reports for KETOCONAZOLE CREAM, 2%, making it a notable side effect.
If you experience dyspnoea while taking KETOCONAZOLE CREAM, 2%, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.